pcsk9-inhibitors · glp1-agonists
최대 4개 패밀리를 선택해 비교합니다.
Oral macrocyclic peptide PCSK9i (enlicitide / Lipfendra) mapped with injectable mAb (evolocumab, alirocumab) and siRNA (inclisiran) class peers for LDL-C lowering.
맵 열기 →GLP-1 receptor agonist chemotypes from exenatide/liraglutide to semaglutide, dual GIP/GLP-1 tirzepatide, triple agonists, and oral small-molecule orforglipron.
맵 열기 →| PCSK9 inhibitor chemical & modality series | GLP-1 / incretin agonist series | |
|---|---|---|
| PCSK9 inhibitor chemical & modality series | 1.00 | 0.15 |
| GLP-1 / incretin agonist series | 0.15 | 1.00 |